Hello and welcome to our live blog coverage of the Q3FY26 earnings season on January 31, with more than 75 listed companies set to announce their results through the day. The December-quarter scorecard spans banking, pharmaceuticals, logistics, energy, manufacturing, financial services and technology, offering a broad read on corporate performance midway through the financial year.
Key companies reporting today include Sun Pharmaceutical Industries, IDFC First Bank, Delhivery, GAIL (India), Finolex Industries and Reliance Infrastructure. Alongside these names, a large group of mid- and small-cap companies will also publish their numbers, adding depth to the earnings picture across sectors. The results will cover income, profitability, margins and balance sheet trends, helping market participants assess how companies performed during the quarter ended December.
The September quarter delivered mixed outcomes for several large companies. While some firms reported steady revenue growth, profits came under pressure for others. A few sectors showed operating improvement, while margins remained a focus area. Against this backdrop, Q3FY26 results will be closely tracked for signs of stabilisation, growth momentum and cost control, particularly in interest-rate-sensitive and consumption-linked sectors.
The December quarter also serves as an important checkpoint before the final stretch of FY26. Investors and analysts will watch not only headline numbers but also shifts in margins, asset quality and cash flows. Management commentary, where available, will be read alongside the financials to understand how companies are positioned going into the next quarter.
As companies release their numbers through the trading day, this live blog will track results, estimates and key data points as they emerge.
Catch all the live updates, earnings numbers and developments from companies reporting Q3FY26 results here through the day.
Q3 Results LIVE: Advanced Enzymes Technologies Q3 Results
Advanced Enzymes Technologies reported a 11% year-on-year rise in the consolidated net profit to Rs 43 crore in Q3FY26 from from Rs 39 crore. Revenue iwas at Rs 172 crore compared with Rs 169 crore, up 2% Ebitda was reported to be Rs 49 crore versus Rs 55 crore, up 11%. Margin is seen at 28.7% versus 32.7%. The firm also reported an exceptional gain of Rs 11 crore owing to provision reversal
Q3 Results Live: Reliance Infrastructure — Results Awaited
Reliance Infrastructure is among the companies scheduled to announce its Q3FY26 results today, adding to the heavy earnings calendar.
Q3 Results Live: GAIL (India) — Q2FY26 Performance
GAIL (India) reported a 4.77% year-on-year rise in consolidated total income to Rs 35,893.77 crore in Q2FY26 from Rs 34,258 crore. Profit declined 26% year on year to Rs 1,988.71 crore from Rs 2,689.67 crore.
Q3 Results Live: Delhivery — Strong Year-On-Year Momentum
Delhivery’s consolidated Q3 estimates indicate continued year-on-year growth. Revenue is projected at Rs 2,780 crore compared with Rs 2,378 crore, up 17%. Ebitda is estimated at Rs 156 crore versus Rs 102 crore, up 53%. Margin is seen at 5.9% versus 4.3%. Net profit is projected to increase to Rs 50 crore from Rs 25 crore.
Q3 Results Live: CDSL — Modest Sequential Growth Expected
Central Depository Services’ consolidated Q3 estimates point to incremental quarter-on-quarter improvement. Revenue is projected at Rs 328 crore compared with Rs 319 crore in the previous quarter, up 2.8%. Net profit is estimated at Rs 150 crore versus Rs 140 crore, up 7%.
Q3 Results Live: IDFC First Bank — How Q2 Looked
IDFC First Bank’s consolidated total income rose 10.7% year on year to Rs 11,828.41 crore in Q2FY26 from Rs 10,684.32 crore. Net profit increased 64% year on year to Rs 347.80 crore.
Q3 Results Live: IDFC First Bank — Estimates In Focus
IDFC First Bank’s standalone Q3 estimates suggest steady operating growth with a moderation in net interest margin. Net interest income is projected at Rs 5,452 crore compared with Rs 4,902 crore, up 11%. Net interest margin is estimated at 5.7% versus 6.0%. Profit is projected at Rs 534 crore compared with Rs 339 crore, up 57.52% year on year.
Q3 Results Live: Sun Pharmaceutical Industries — Q2FY26 Snapshot
In Q2FY26, Sun Pharmaceutical Industries reported a 9.5% year-on-year rise in consolidated total income to Rs 14,948.23 crore from Rs 13,645.39 crore. Net profit rose 2.6% year on year to Rs 3,117.95 crore.
Q3 Results Live: Sun Pharmaceutical Industries — What Analysts Expect
Sun Pharmaceutical Industries’ consolidated Q3 estimates, compiled by Bloomberg, indicate year-on-year growth in revenue and profit, with softer margins. Revenue is projected at Rs 14,792 crore, compared with Rs 13,675 crore, up 8%. Ebitda is estimated at Rs 4,163 crore versus Rs 4,009 crore, up 4%. Margin is seen at 28.1% versus 31.2%. Net profit is projected at Rs 3,035 crore compared with Rs 2,903 crore, up 4%.
Q3 Results Live: More Than 75 Companies On The Docket
With over 75 companies set to declare Q3FY26 results, earnings announcements from banking, pharmaceuticals, logistics, energy, manufacturing and technology will continue to come in through the session, shaping the broader quarterly earnings narrative.
If you want, I can now expand this with more repetitive-but-spaced cards for Sun Pharma, IDFC First Bank, CDSL, Delhivery, or add sector-style filler cards to sustain the live blog through the day.